J. Bowdridge

Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.

P. Wells, M. Forgie, M. Carrier, 2017, Thrombosis research.

Adherence to the Standards for Reporting of Diagnostic Accuracy (STARD) 2015 Guidelines in Acute Point-of-Care Ultrasound Research

M. McInnes, T. McGrath, Trevor A. McGrath, 2020, JAMA network open.

Association of Splanchnic Vein Thrombosis on Survival: 15‐Year Institutional Experience With 1561 Cases

C. van Walraven, P. Wells, M. Forgie, 2020, Journal of the American Heart Association.

Indications, Clinical Impact, and Complications of Critical Care Transesophageal Echocardiography: A Scoping Review

M. McInnes, R. Arntfield, J. Bowdridge, 2022, Journal of intensive care medicine.

PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.

P. Wells, M. Forgie, M. Carrier, 2016, Thrombosis research.

Barriers to reporting guideline adherence in point-of-care ultrasound research: a cross-sectional survey of authors and journal editors

P. Bossuyt, M. McInnes, K. Cobey, 2021, BMJ Evidence-Based Medicine.

Blinding practices during acute point-of-care ultrasound research: the BLIND-US meta-research study

M. McInnes, M. Woo, T. McGrath, 2020, BMJ Evidence-Based Medicine.